Vieth v. MOM Enterprises — Vitamin D Delivery Patent Claims Were Obvious

Background

The Vieths’ U.S. Patent No. 9,066,958 claims a method of delivering vitamin D by placing a single drop of vitamin D in a medium-chain triglyceride oil on an object that a person sucks or licks. Some claims specifically identify an infant and a nipple or pacifier. MOM Enterprises, maker of Mommy’s Bliss vitamin D drops, challenged claims 1 and 3–5 in inter partes review.

The Patent Trial and Appeal Board found the claims obvious over references describing vitamin D oil administered from a spoon, the oil’s composition, and the use of pacifiers to trigger an infant’s sucking reflex. It also found that evidence of commercial success, praise, long-felt need, and copying lacked a sufficient connection—or “nexus”—to the claimed method.

The Court’s Holding

The Federal Circuit affirmed. Substantial evidence supported the Board’s finding that the earlier spoon method inherently disclosed, or at least suggested, the requirement that the drop adhere without preventing efficient removal. A drop could roll into the spoon’s bowl or leave a film and still satisfy the agreed claim construction if the infant could lick or suck it off efficiently.

The court also upheld the use of a pacifier reference. A skilled artisan would have had reason to replace the spoon with a pacifier because a pacifier more reliably triggers an infant’s sucking reflex and therefore helps deliver the full dose. Several of the Vieths’ contrary arguments were forfeited because they were raised only in a sur-reply or at oral argument before the Board.

Finally, the objective evidence did not overcome the obviousness showing. The commercial products’ labels also instructed users to mix the drops with milk, juice, formula, or food—uses outside the claims—so the products were not coextensive with the patented method. The evidence did not show that sales or praise resulted from the claimed application technique, and the record already disclosed a workable way to administer a precise vitamin D dose to an infant.

Key Takeaways

• A physical result can be inherent when the prior art uses materially the same composition under the relevant conditions.
• Arguments introduced for the first time in an IPR sur-reply or at oral argument may be forfeited.
• Commercial success and praise matter only when tied to what the patent actually claims.
• Alternative, nonclaimed uses on a product label can defeat a presumption that the product is coextensive with the claims.

Why It Matters

The decision shows how claim construction, procedural preservation, and proof of nexus can determine an obviousness appeal. Product-market evidence is not self-proving: patent owners need evidence that customers buy or praise the product because of the claimed feature, especially when the same product supports substantial noninfringing uses.